Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novo Nordisk Establishes Type 1 Diabetes R&D Center in Seattle
Yahoo
Monday, January 23, 2012 - 12:44pm
tags:
R&D, Novo Nordisk, type 1 diabetes
Tysabri label change could add $1B to sales
Fierce Pharma
Monday, January 23, 2012 - 12:00pm
tags:
Tysabri, MS, multiple sclerosis, Biogen Idec
Celgene Corp Fourth Quarter Earnings Sneak Peek
Yahoo/Wall St Cheat Sheet
Monday, January 23, 2012 - 11:56am
tags:
Celgene, earnings
CEL-SCI says Multikine Phase III trial launched in dozens of hospitals
The Fly on the Wall
Monday, January 23, 2012 - 11:25am
tags:
Cel-Sci, Multikine, head and neck cancer
FDA extends review of Alexza product, shares fall
Reuters
Monday, January 23, 2012 - 11:03am
tags:
FDA, Alexza, Adasuve, antipsychotics
Abbott: The Best Buy In This Group Of 5 Big Pharma Stocks
Seeking Alpha
Monday, January 23, 2012 - 11:02am
tags:
Abbott Laboratories, Merck, Pfizer, GSK, Bristol-Myers Squibb
Forbes Earnings Preview: Amgen
Forbes
Monday, January 23, 2012 - 11:01am
tags:
earnings, Amgen
Perrigo, Apotex Sued by Meda Over Generic Version of Astepro Nasal Spray
Bloomberg
Monday, January 23, 2012 - 11:00am
tags:
Astepro, Perrigo, Meda, Apotex, generics
2 Pharmaceutical Stocks Ready To Move
Seeking Alpha
Monday, January 23, 2012 - 9:52am
tags:
Amylin, Prolor
The Medicines Company Settles Angiomax(R) (Bivalirudin) Patent Litigations With App Pharmaceuticals
Yahoo
Monday, January 23, 2012 - 9:51am
tags:
Angiomax, patents, Medicines Company, APP
Earnings Preview: Bristol-Myers
Yahoo/Zacks
Monday, January 23, 2012 - 9:49am
tags:
earnings, Bristol-Myers Squibb
Earnings Preview For Johnson & Johnson 4Q 2011
Seeking Alpha
Monday, January 23, 2012 - 9:49am
tags:
JNJ, earnings
Pot-based prescription drug looks for FDA OK
Yahoo/AP
Monday, January 23, 2012 - 9:48am
tags:
marijuana, FDA, GW Pharma, cancer pain
Seattle Genetics: Boxed Warning Is A Non-Event
Seeking Alpha
Sunday, January 22, 2012 - 12:32pm
tags:
Seattle Genetics, progressive multifocal leukoencephalopathy, PML, Adcetris, Hodgkin's lymphoma, anaplastic large-cell lymphoma
Teva Rises to Eight-Month High on Novartis News
BusinessWeek
Sunday, January 22, 2012 - 12:26pm
tags:
Teva Pharmaceuticals, Gilenya, Novartis, Copaxone, multiple sclerosis
6 Biotech Plays With High Risk/Reward Potential
Seeking Alpha
Sunday, January 22, 2012 - 12:20pm
tags:
Vertex Pharmaceuticals, Chelsea Therapeutics, ONYX Pharmaceuticals, Amarin, Ariad Pharmaceuticals, Cell Therapeutics
2 Positive Signs for Sequenom
Motley Fool
Sunday, January 22, 2012 - 12:18pm
tags:
Sequenom
FDA advisers give gel a failing grade
StL Today, MO
Saturday, January 21, 2012 - 5:57pm
tags:
Columbia Laboratories, Crinone Labs, preterm birth, Watson Pharmaceuticals
La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist
Enhanced Online News
Saturday, January 21, 2012 - 5:50pm
tags:
GCS-100, La Jolla Pharmaceutical
Impetigo - Ozenoxacin Phase lll Trial
Medical News Today
Saturday, January 21, 2012 - 5:18pm
tags:
Ferrer, ozenoxacin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.